光子放疗稳健优化:模型、范式与报告的范围综述
多数研究集中于前列腺、乳腺或肺癌,以基于场景的最坏情况(minimax)优化为主;直接临床实施报告稀缺,不确定性模型与报告异质性限制比较与整合。
要点
- 基于场景的最坏情况优化是临床导向工作的主导范式。
- 不确定性建模主要关注刚性摆位误差,呼吸运动等纳入较少。
- 直接临床实施报告稀缺,稳健性报告异质性大。
核心结论
- 光子稳健计划在技术上可行,与基于外扩边界的计划相比通常维持或改善靶区覆盖和危及器官保护。
- 不确定性模型、优化配置和稳健性报告的异质性限制了比较与整合。
- 提出务实的最低标准以支持未来共识和更广泛的临床采用。
研究设计与样本
- 范围综述,电子检索Scopus、PubMed和Google Scholar(2000-2025年,英文)。
- 纳入将建模不确定性纳入优化过程并报告至少一项稳健性相关结局的计划研究。
主要发现
- 多数研究探讨前列腺、乳腺或肺癌,使用调强放疗或容积旋转调强放疗,在商业或研究治疗计划系统中进行。
- 基于场景的最坏情况(minimax)优化是临床导向工作的主导范式。
- 机会约束、条件风险价值、分布稳健和自适应公式局限于小型方法学系列。
- 不确定性建模主要关注刚性摆位误差;较少研究纳入呼吸运动、分次间解剖变化、剂量计算不确定性或生物学变异。
- 稳健性评估使用基于场景的剂量体积指标、概率覆盖指标、复合稳健性指数,较少使用生物学终点。
临床怎么用
- 临床导向的稳健优化可优先考虑基于场景的最坏情况优化范式。
- 实施稳健优化时应明确所建模的不确定性类型,并注意当前证据中刚性摆位误差之外的建模较少。
- 稳健性报告宜参考所提出的务实最低标准,以提高可比性。
局限性
- 不确定性模型、优化配置和稳健性报告的异质性限制了研究间的比较与综合。
- 直接临床实施报告稀缺。
- 检索限于英文文献(2000-2025年),可能遗漏非英文研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Robust optimisation offers an alternative to conventional margin-based photon radiotherapy planning by explicitly modelling uncertainty, but practice is variable and not standardised. MATERIALS AND METHODS: A scoping review was conducted to map robust optimisation for photon external beam radiotherapy. Electronic searches of Scopus, PubMed and Google Scholar (2000-2025, English language) identified planning studies that incorporated modelled uncertainties into the optimisation process and reported at least one robustness-related outcome. Data were charted on clinical context, uncertainty models, optimisation paradigms, robustness metrics and evidence for clinical implementation. RESULTS: Seventy-one studies were included. Most investigated prostate, breast or lung cancer and used intensity-modulated radiotherapy or volumetric-modulated arc therapy in commercial or research treatment planning systems. Scenario-based worst-case (minimax) optimisation was the dominant paradigm in clinically oriented work, while chance-constrained, conditional value at-risk, distributionally robust and adaptive formulations were confined to small methodological series. Uncertainty modelling focused mainly on rigid set-up error; fewer studies incorporated respiratory motion, inter-fraction anatomical change, dose-calculation uncertainty or biological variation. Robustness was evaluated with diverse scenario-based dose-volume metrics, probabilistic coverage measures, composite robustness indices and, less often, biological endpoints. Direct clinical implementation reports were scarce. CONCLUSION: Robust photon planning is technically feasible and generally maintains or improves target coverage and organ sparing compared with margin-based planning. However, heterogeneity in uncertainty models, optimisation configuration and robustness reporting limits comparison and synthesis. Pragmatic minimum standards are proposed to support future consensus and wider clinical adoption.
引用
- Wright B, Ebert M, Kendrick J, et al. Robust optimisation for photon radiotherapy: A scoping review of models, paradigms, and reporting. Radiother Oncol. 2026. PMID: 42480714. doi:10.1016/j.radonc.2026.111709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。